A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Individuals in NSW will have the option to receive their ADHD medication resupply from their regular doctor for the first ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

Analysis: The government is expanding access to ADHD diagnosis, but experts warn medication alone won't fix NZ's systemic ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

NHS England mental health survey shows record rise in psychiatric conditions, self-harm, and suicidal ideation.